FELOCEL CVR
Vaccine for the prevention of viral rhinotracheitis, calicivirus, and panleukopenia in cats
Prevention of viral rhinotracheitis, calicivirus infection, and panleukopenia in cats
High immunogenicity — components grown on feline cell culture
Approved for use in pregnant and lactating cats
Available as
Vaccine (injection)
For use with
Cats
Strength
Live attenuated vaccine
How it is supplied
25 doses per pack
Drug description
Feline Vaccine FELOCEL CVR
Felocel CVR contains attenuated rhinotracheitis virus (strain FVRm), calicivirus (strain F-9), and feline panleukopenia virus (strain Snow Leopard), along with the preservative gentamicin and a stabilizer.
The vaccine establishes immune response against rhinotracheitis, calicivirus, and panleukopenia 21 days after completion of vaccination. Duration of immunity is at least 12 months.
Healthy cats are vaccinated from 8 weeks of age. With a 3-week interval — three doses (at 8, 11, and 14 weeks); with a 4-week interval — two doses (at 8 and 12 weeks). The vaccine is administered subcutaneously or intramuscularly at a dose of 1 mL.
Annual revaccination is required. Store at 2–7°C. Shelf life: 18 months.
Contact us
Start cooperation with industry leaders
